(VIANEWS) – Old Second Bancorp (OSBC), Masimo Corporation (MASI), MSC Industrial Direct Company (MSM) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Old Second Bancorp (OSBC)

87.4% sales growth and 5.19% return on equity

Old Second Bancorp, Inc. is the bank holding company of Old Second National Bank and provides various banking services.

Old Second Bancorp’s sales growth this year is expected to be 65.9% and 10.4% for next year.

Year-on-year quarterly revenue growth grew by 44.6%, now sitting on 148.55M for the twelve trailing months.

Volume

Today’s last reported volume for Old Second Bancorp is 1937720 which is 682.33% above its average volume of 247683.

Old Second Bancorp’s sales growth for the next quarter is 87.4%. The company’s growth estimates for the current quarter and the next is 10% and 27.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.19%.

Volatility

Old Second Bancorp’s last day, last week, and last month’s current intraday variation average was 0.37%, 1.99%, and 1.78%, respectively.

Old Second Bancorp’s highest amplitude of average volatility was 3.42% (day), 3.57% (last week), and 2.95% (last month), respectively.

Old Second Bancorp’s Stock Yearly Top and Bottom Value

Old Second Bancorp’s stock is valued at $13.46 at 16:22 EST, way below its 52-week high of $15.68 and way above its 52-week low of $11.16.

Old Second Bancorp’s Moving Average

Old Second Bancorp’s worth is under its 50-day moving average of $14.35 and below its 200-day moving average of $13.68.

2. Masimo Corporation (MASI)

79.9% sales growth and 15.31% return on equity

Masimo Corporation designs, produces, and sells noninvasive monitoring technology and solutions for hospital automation worldwide.

Masimo Corporation’s sales growth this year is anticipated to be 66.4% and 19.3% for next year.

Year-on-year quarterly revenue growth grew by 1.7%, now sitting on 1.24B for the twelve trailing months.

Volume

Today’s last reported volume for Masimo Corporation is 449707 which is 53.02% below its average volume of 957251.

Masimo Corporation’s sales growth for the next quarter is 79.9%. The company’s growth estimates for the current quarter and the next is 27.7% and 20.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.31%.

Volatility

Masimo Corporation’s last day, last week, and last month’s current intraday variation average was 2.19%, 2.60%, and 2.49%, respectively.

Masimo Corporation’s highest amplitude of average volatility was 2.99% (day), 3.84% (last week), and 3.76% (last month), respectively.

Masimo Corporation’s Stock Yearly Top and Bottom Value

Masimo Corporation’s stock is valued at $138.60 at 16:22 EST, way below its 52-week high of $305.21 and way above its 52-week low of $112.07.

Masimo Corporation’s Moving Average

Masimo Corporation’s worth is higher than its 50-day moving average of $131.79 and way below its 200-day moving average of $211.37.

3. MSC Industrial Direct Company (MSM)

69.9% sales growth and 25.25% return on equity

MSC Industrial Direct Co., Inc. distributes, along with its subsidiaries, metalworking, maintenance, repair, operations (MRO), products in the United States, Canada, Mexico, the United Kingdom.

MSC Industrial Direct Company’s sales growth this year is expected to be 60.6% and 4.9% for next year.

Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 3.41B for the twelve trailing months.

Volume

Today’s last reported volume for MSC Industrial Direct Company is 981738 which is 133.82% above its average volume of 419866.

MSC Industrial Direct Company’s sales growth is a negative 0% for the present quarter and 69.9% for the next. The company’s growth estimates for the present quarter and the next is 74.6% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.25%.

Volatility

MSC Industrial Direct Company’s last day, last week, and last month’s current intraday variation average was 2.74%, 2.25%, and 1.21%, respectively.

MSC Industrial Direct Company’s highest amplitude of average volatility was 4.09% (day), 2.97% (last week), and 2.09% (last month), respectively.

MSC Industrial Direct Company’s Stock Yearly Top and Bottom Value

MSC Industrial Direct Company’s stock is valued at $72.91 at 16:22 EST, way under its 52-week high of $92.04 and higher than its 52-week low of $72.79.

MSC Industrial Direct Company’s Moving Average

MSC Industrial Direct Company’s value is way under its 50-day moving average of $83.07 and way below its 200-day moving average of $82.39.

4. BBQ Holdings (BBQ)

48.4% sales growth and 52.07% return on equity

BBQ Holdings, Inc. creates, owns, manages, franchises and operates casual and fast-food restaurants in America, Canada, the United Arab Emirates, and internationally under the Famous Dave’s, Clark Crew BBQ, Granite City Food & Brewery, Real Urban Barbecue, and Clark Crew BBQ brands.

BBQ Holdings ‘s sales growth this year is anticipated to be 46.3% and 8.5% for next year.

Year-on-year quarterly revenue growth grew by 72%, now sitting on 233.31M for the twelve trailing months.

Volume

Today’s last reported volume for BBQ Holdings is 19176 which is 57.51% below its average volume of 45131.

BBQ Holdings ‘s sales growth for the next quarter is 48.4%. The company’s growth estimates for the ongoing quarter and the next is 24% and 88.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 52.07%.

Volatility

BBQ Holdings ‘s last day, last week, and last month’s current intraday variation average was 5.83%, 1.70%, and 3.53%, respectively.

BBQ Holdings ‘s highest amplitude of average volatility was 4.97% (day), 4.15% (last week), and 6.40% (last month), respectively.

BBQ Holdings ‘s Stock Yearly Top and Bottom Value

BBQ Holdings ‘s stock is valued at $11.67 at 16:22 EST, way under its 52-week high of $19.75 and above its 52-week low of $10.75.

BBQ Holdings ‘s Moving Average

BBQ Holdings ‘s value is way below its 50-day moving average of $13.69 and way below its 200-day moving average of $14.16.

5. OneWater Marine (ONEW)

42.7% sales growth and 49.56% return on equity

OneWater Marine Inc. is a retailer of recreational boats in the United States.

OneWater Marine’s sales growth this year is anticipated to be 42.1% and 8.8% for next year.

Year-on-year quarterly revenue growth grew by 34.1%, now sitting on 1.46B for the twelve trailing months.

Volume

Today’s last reported volume for OneWater Marine is 68444 which is 48.78% below its average volume of 133641.

OneWater Marine’s sales growth is a negative 0% for the ongoing quarter and 42.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 13.8% and 7.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.56%.

Volatility

OneWater Marine’s last day, last week, and last month’s current intraday variation average was 0.97%, 3.57%, and 2.47%, respectively.

OneWater Marine’s highest amplitude of average volatility was 3.52% (day), 5.94% (last week), and 5.15% (last month), respectively.

OneWater Marine’s Stock Yearly Top and Bottom Value

OneWater Marine’s stock is valued at $32.21 at 16:22 EST, way below its 52-week high of $62.79 and higher than its 52-week low of $29.86.

OneWater Marine’s Moving Average

OneWater Marine’s worth is under its 50-day moving average of $33.37 and way below its 200-day moving average of $43.62.

6. WESCO (WCC)

12.3% sales growth and 13.11% return on equity

WESCO International Inc. is a distributor of electrical and industrial maintenance, repair and operating (MRO), and original equipment manufacturer products and construction material in North America as well as internationally.

WESCO’s sales growth this year is anticipated to be 13.5% and 3.7% for next year.

Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 18.22B for the twelve trailing months.

Volume

Today’s last reported volume for WESCO is 332316 which is 46.81% below its average volume of 624819.

WESCO’s sales growth for the next quarter is 12.3%. The company’s growth estimates for the present quarter and the next is 42% and 37.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.11%.

Volatility

WESCO’s last day, last week, and last month’s current intraday variation average was 1.37%, 4.53%, and 3.52%, respectively.

WESCO’s highest amplitude of average volatility was 3.58% (day), 5.80% (last week), and 5.10% (last month), respectively.

WESCO’s Stock Yearly Top and Bottom Value

WESCO’s stock is valued at $110.39 at 16:23 EST, way under its 52-week high of $144.43 and way above its 52-week low of $93.80.

WESCO’s Moving Average

WESCO’s value is way under its 50-day moving average of $124.34 and way below its 200-day moving average of $124.95.

7. Pfizer (PFE)

8.9% sales growth and 31.87% return on equity

Pfizer Inc. designs, manufactures and markets healthcare products around the world.

Pfizer’s sales growth this year is expected to be 28.8% and a negative 25.2% for next year.

Year-on-year quarterly revenue growth grew by 106.8%, now sitting on 81.29B for the twelve trailing months.

Volume

Today’s last reported volume for Pfizer is 11454800 which is 54.02% below its average volume of 24917300.

News about Pfizer(PFE) today

  • Roivant, Pfizer unveil priovant therapeutics focused on autoimmune disease treatments, roivant stock surges. According to today’s article on MarketWatch, "Roivant’s stock has tumbled 53.6% year to date through Monday, while Pfizer shares have lost 12.1% and the S&P 500 has declined 18.2%.", "The companies said Priovant was formed through a deal between Roivant and Pfizer in September 2021, in which Pfizer licensed oral and topical brepocitinib, a potential autoimmune disease treatment, for global development rights and U.S. and Japan commercial rights to Priovant. "

Pfizer’s sales growth for the next quarter is 8.9%. The company’s growth estimates for the ongoing quarter and the next is 89.7% and 41%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.87%.

Volatility

Pfizer’s last day, last week, and last month’s current intraday variation average was 0.56%, 1.84%, and 2.15%, respectively.

Pfizer’s highest amplitude of average volatility was 1.87% (day), 2.27% (last week), and 2.91% (last month), respectively.

Pfizer’s Stock Yearly Top and Bottom Value

Pfizer’s stock is valued at $50.72 at 16:23 EST, way under its 52-week high of $61.71 and way above its 52-week low of $38.82.

Pfizer’s Moving Average

Pfizer’s worth is above its 50-day moving average of $50.59 and higher than its 200-day moving average of $50.24.

Previous days news about Pfizer(PFE)

  • According to MarketWatch on Thursday, 23 June, "Shares of BioNTech, which co-developed the first approved mRNA-based vaccine against COVID with partner Pfizer Inc. , were up 1.1% premarket, but have fallen 52% in the year to date, while the SPDR S&P Biotech ETF has fallen 35% and the S&P 500 has fallen 21%."
  • According to FXStreet on Monday, 27 June, "BioNTech (BNTX) and Pfizer (PFE) say the omicron booster works better than the original."
  • According to MarketWatch on Friday, 24 June, "The move is expected to lead CDC head Dr. Rochelle Walensky to sign off on the vaccine for that age group, offering a second option along with the vaccine developed by Pfizer and German partner BioNTech . "
  • According to MarketWatch on Friday, 24 June, "The move is expected to lead CDC head Dr. Rochelle Walensky to sign off on the vaccine for that age group, offering a second option along with the vaccine developed by Pfizer and German partner BioNTech ."

LEAVE A REPLY

Please enter your comment!
Please enter your name here